Add-on Acquisition • Life Science

FHI Clinical Acquires TCD Global

On December 2, 2021, FHI Clinical acquired life science company TCD Global

Acquisition Context

This is FHI Clinical’s 1st transaction in the Life Science sector.
This is FHI Clinical’s 1st transaction in South Africa.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	December 2, 2021
Target	TCD Global
Sector	Life Science
Buyer(s)	FHI Clinical
Deal Type	Add-on Acquisition

Target Company

TCD Global

Centurion, South Africa

TCD Global is a Contract Research Organisation that has been awarded over 300 clinical trial contracts, across 16 therapeutic areas, by more than 120, predominantly international, clients. TCD Global was founded in 2000 and is based in Centurion, South Africa.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

FHI Clinical

Durham, North Carolina, United States

Category	Company
Founded	2019
Sector	Life Science

DESCRIPTION

FHI Clinical is a full-service contract research organization (CRO) with global expertise, responsive approaches, and proven solutions to manage complex clinical research around the world. FHI Clinical was founded in 2019 and is based in Durham, North Carolina.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: South Africa	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - South Africa M&A - 2021 M&A